Full Text View
Tabular View
No Study Results Posted
Related Studies
Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
This study is currently recruiting participants.
Verified July 2012 by Cornea and Laser Eye Institute
Study NCT01152541   Information provided by Cornea and Laser Eye Institute

First Received on June 22, 2010.   Last Updated on July 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Keratoconus
Corneal Ectasia
Additional conditions recognized in this trial
Corneal Diseases
Dilatation, Pathologic
More general conditions related to this trial
Eye Diseases
Pathological Conditions, Anatomical
Interventions listed in this trial
Riboflavin/Dextran
Hypotonic Riboflavin
Additional drug interventions recognized in this trial
Dextrans
Riboflavin
More general drug interventions related to this trial
Anticoagulants
Blood Substitutes
Dermatologic Agents
Growth Substances
Hematologic Agents
Micronutrients
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Plasma Substitutes
Radiation-Sensitizing Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Cornea and Laser Eye Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services